Table 2.
The association between prevalent genotypes of human papilloma virus persistent positivity and cervical cancer clinical pathological data
Data |
No. 1108 |
HPV + |
χ2 |
P |
Multiple HPV(+) |
χ2 |
P |
HPV 16+ |
χ2 |
P |
HPV 58+ |
χ2 |
P |
HPV 18+ |
χ2 |
P |
HPV 52+ |
χ2 |
P |
HPV 33+ |
χ2 |
P |
Age |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<35 |
376 |
326 |
0.903 |
0.380 |
53 |
5.048 |
0.025 |
69 |
3.013 |
0.097 |
18 |
6.004 |
0.016 |
21 |
0.140 |
0.789 |
14 |
0.658 |
0.446 |
6 |
7.518 |
0.005 |
≥35 |
732 |
649 |
143 |
105 |
65 |
45 |
35 |
36 |
||||||||||||||
FIGO stage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ia~Ib |
643 |
562 |
0.511 |
0.513 |
115 |
0.040 |
0.873 |
91 |
2.786 |
0.112 |
55 |
2.497 |
0.133 |
38 |
0.006 |
1.000 |
28 |
0.017 |
0.884 |
26 |
0.269 |
0.636 |
IIa~IV |
465 |
413 |
81 |
83 |
28 |
28 |
21 |
16 |
||||||||||||||
Grade |
1069 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
G1 ~ G2 |
531 |
479 |
1.314 |
0.28 |
109 |
3.387 |
0.069 |
81 |
0.810 |
0.407 |
40 |
0.003 |
1.000 |
30 |
0.501 |
0.526 |
25 |
0.037 |
0.884 |
22 |
0.472 |
0.523 |
G3 |
538 |
496 |
87 |
93 |
41 |
36 |
24 |
18 |
||||||||||||||
Lymph metastasis |
1043 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
no |
739 |
692 |
0.800 |
0.417 |
135 |
0.094 |
0.792 |
113 |
3.533 |
0.068 |
54 |
1.077 |
0.312 |
36 |
9.074 |
0.005 |
34 |
0.000 |
1.000 |
27 |
0.914 |
0.386 |
yes |
304 |
280 |
58 |
61 |
28 |
30 |
14 |
15 |
||||||||||||||
Histology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Squamous carcinoma |
767 |
681 |
1.477 | 0.230 |
129 |
1.298 | 0.268 |
121 |
0.010 | 1.000 |
57 |
0.013 | 0.902 |
38 |
4.469 | 0.039 |
35 |
0.117 | 0.874 |
28 |
0.134 | 0.734 |
Adeno- carcinoma |
341 | 294 | 67 | 53 | 26 | 28 | 14 | 14 |